scholarly journals Clinical application of High-flow nasal cannula oxygen therapy in acute heart failure

2021 ◽  
Author(s):  
Xiong LIU ◽  
Rong WU ◽  
Liren LAI ◽  
Jiyan LIN
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Clinical Application ◽  
Oxygen Therapy ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula

scholarly journals CLINICAL EFFICACY OF HIGH-FLOW OXYGEN THERAPY THROUGH NASAL CANNULA IN PATIENTS WITH ACUTE HEART FAILURE

2017 ◽  
Vol 69 (11) ◽  
pp. 791
Author(s):  
Min Gyu Kang ◽  
Hyun Woong Park ◽  
Jin-Sin Koh ◽  
Seok-Jae Hwang ◽  
Jin-Yong Hwang ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Clinical Efficacy ◽  
Oxygen Therapy ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Oxygen

scholarly journals Benefits of High-Flow Nasal Cannula Therapy for Acute Pulmonary Edema in Patients with Heart Failure in the Emergency Department: A Prospective Multi-Center Randomized Controlled Trial

2020 ◽  
Vol 9 (6) ◽  
pp. 1937 ◽  
Author(s):  
Dong Ryul Ko ◽  
Jinho Beom ◽  
Hye Sun Lee ◽  
Je Sung You ◽  
Hyun Soo Chung ◽  
...  
Keyword(s):  
Heart Failure ◽  
Emergency Department ◽  
Pulmonary Edema ◽  
Oxygen Therapy ◽  
Controlled Trial ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula ◽  
Arterial Blood Gas ◽  
Arterial Blood

Heart failure patients with pulmonary edema presenting to the emergency department (ED) require an effective approach to deliver sufficient oxygen and reduce the rate of intubation and mechanical ventilation in the ED; conventional oxygen therapy has proven ineffective in delivering enough oxygen to the tissues. We aimed to identify whether high-flow nasal cannula (HFNC) therapy over time improved the respiratory rate (RR), lactate clearance, and certain arterial blood gas (ABG) parameters, in comparison with conventional oxygen therapy, in patients with cardiogenic pulmonary edema. This prospective, multi-institutional, and interventional study (clinical trial, reference KCT0004578) conducted between 2016 and 2019 included adult patients diagnosed with heart failure within the previous year and pulmonary edema confirmed at admission. Patients were randomly assigned to the conventional or HFNC group and treated with the goal of maintaining oxygen saturation (SpO2) ≥ 93. We obtained RR, SpO2, lactate levels, and ABG parameters at baseline and 30 and 60 min after randomization. All parameters showed greater improvement with HFNC therapy than with conventional therapy. Significant changes in ABG parameters were achieved within 30 min. HFNC therapy could therefore be considered as initial oxygen therapy. Physicians may consider advanced ventilation if there is no significant improvement in ABG parameters within 30 min of HFNC therapy.

scholarly journals Clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure

2019 ◽  
Vol 11 (2) ◽  
pp. 410-417 ◽  
Author(s):  
Min Gyu Kang ◽  
Kyehwan Kim ◽  
Sunmi Ju ◽  
Hyun Woong Park ◽  
Seung Jun Lee ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Clinical Efficacy ◽  
Oxygen Therapy ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Oxygen

scholarly journals Erratum to clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure

2019 ◽  
Vol 11 (3) ◽  
pp. E65-E65
Author(s):  
Min Gyu Kang ◽  
Kyehwan Kim ◽  
Sunmi Ju ◽  
Hyun Woong Park ◽  
Seung Jun Lee ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Clinical Efficacy ◽  
Oxygen Therapy ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Oxygen

The starting rate for high‐flow nasal cannula oxygen therapy in infants with bronchiolitis: Is clinical judgment enough?

2021 ◽  
Author(s):  
Paola Papoff ◽  
Elena Caresta ◽  
Stefano Luciani ◽  
Alessandra Pierangeli ◽  
Carolina Scagnolari ◽  
...  
Keyword(s):  
Clinical Judgment ◽  
Oxygen Therapy ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula
Sign in / Sign up

Export Citation Format

Share Document